These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 34338150)
1. Prognostic marker identification based on weighted gene co-expression network analysis and associated Guo H; Yang J; Liu S; Qin T; Zhao Q; Hou X; Ren L Bioengineered; 2021 Dec; 12(1):4666-4680. PubMed ID: 34338150 [TBL] [Abstract][Full Text] [Related]
2. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis. Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391 [TBL] [Abstract][Full Text] [Related]
3. Bioinformatic analysis of hub markers and immune cell infiltration characteristics of gastric cancer. Li C; Yang T; Yuan Y; Wen R; Yu H Front Immunol; 2023; 14():1202529. PubMed ID: 37359529 [TBL] [Abstract][Full Text] [Related]
4. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis. Li D; Yin Y; He M; Wang J Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701 [TBL] [Abstract][Full Text] [Related]
5. Identification of GNG7 as a novel biomarker and potential therapeutic target for gastric cancer via bioinformatic analysis and Duan H; Chen B; Wang W; Luo H Aging (Albany NY); 2023 Feb; 15(5):1445-1474. PubMed ID: 36863706 [TBL] [Abstract][Full Text] [Related]
6. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer. Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489 [TBL] [Abstract][Full Text] [Related]
7. Develop a circular RNA-related regulatory network associated with prognosis of gastric cancer. Wei S; Teng S; Yao J; Gao W; Zang J; Wang G; Hu Z Cancer Med; 2020 Nov; 9(22):8589-8599. PubMed ID: 32902196 [TBL] [Abstract][Full Text] [Related]
8. Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing. Zhao X; Wu S; Jing J Pathol Oncol Res; 2021; 27():1609955. PubMed ID: 34899080 [No Abstract] [Full Text] [Related]
9. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis. Li T; Gao X; Han L; Yu J; Li H World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304 [TBL] [Abstract][Full Text] [Related]
10. Identification of early diagnostic biomarkers via WGCNA in gastric cancer. Rezaei Z; Ranjbaran J; Safarpour H; Nomiri S; Salmani F; Chamani E; Larki P; Brunetti O; Silvestris N; Tavakoli T Biomed Pharmacother; 2022 Jan; 145():112477. PubMed ID: 34864309 [TBL] [Abstract][Full Text] [Related]
11. Identifying Diagnostic and Prognostic Differentially Expressed Genes of Gastric Cancer Based on Bioinformatics Analyses of RNA-seq Data. Wang M; Jiang X; Xu S; Deng Y; Cao T; Cheng Y; Zhang WH; Zhang L; Hu J Genet Test Mol Biomarkers; 2022 Nov; 26(11):512-521. PubMed ID: 36383109 [No Abstract] [Full Text] [Related]
12. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer. Zhang X; Jiang Y; Xie Y; Leng X; Song F DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786 [TBL] [Abstract][Full Text] [Related]
13. Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis. Ma Z; Xu J; Ru L; Zhu W Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33754626 [TBL] [Abstract][Full Text] [Related]
14. Identification of SCN7A as the key gene associated with tumor mutation burden in gastric cancer. Li W; Zhou K; Li M; Hu Q; Wei W; Liu L; Zhao Q BMC Gastroenterol; 2022 Feb; 22(1):45. PubMed ID: 35123417 [TBL] [Abstract][Full Text] [Related]
15. Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer. Zhao Q; Xie J; Xie J; Zhao R; Song C; Wang H; Rong J; Yan L; Song Y; Wang F; Xie Y Cancer Biomark; 2021; 31(1):59-75. PubMed ID: 33780362 [TBL] [Abstract][Full Text] [Related]
16. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer. Yang C; Gong A Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215 [No Abstract] [Full Text] [Related]
17. ACAN, MDFI, and CHST1 as Candidate Genes in Gastric Cancer: A Comprehensive Insilco Analysis. Vafaeie F; Nomiri S; Ranjbaran J; Safarpour H Asian Pac J Cancer Prev; 2022 Feb; 23(2):683-694. PubMed ID: 35225482 [TBL] [Abstract][Full Text] [Related]
18. Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients. Sun T; Wang D; Ping Y; Sang Y; Dai Y; Wang Y; Liu Z; Duan X; Tao Z; Liu W Int J Oncol; 2020 Feb; 56(2):460-469. PubMed ID: 31894266 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of gastric cancer-associated gene signatures: Evidence based on a meta-analysis using integrated bioinformatics methods. Wang J; Gao P; Song Y; Sun J; Chen X; Yu H; Wang Y; Wang Z J Cell Mol Med; 2018 Nov; 22(11):5743-5747. PubMed ID: 30133128 [TBL] [Abstract][Full Text] [Related]
20. Integrated analysis identifies oxidative stress genes associated with progression and prognosis in gastric cancer. Wu Z; Wang L; Wen Z; Yao J Sci Rep; 2021 Feb; 11(1):3292. PubMed ID: 33558567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]